GMPPB
Basic information
Region (hg38): 3:49716844-49723973
Links
Phenotypes
GenCC
Source:
- muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A14 (Definitive), mode of inheritance: AR
- congenital myasthenic syndrome (Strong), mode of inheritance: AR
- autosomal recessive limb-girdle muscular dystrophy type 2T (Strong), mode of inheritance: AR
- muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A14 (Strong), mode of inheritance: AR
- autosomal recessive limb-girdle muscular dystrophy type 2T (Moderate), mode of inheritance: AR
- muscle-eye-brain disease (Supportive), mode of inheritance: AR
- congenital myasthenic syndromes with glycosylation defect (Supportive), mode of inheritance: AR
- autosomal recessive limb-girdle muscular dystrophy type 2T (Supportive), mode of inheritance: AR
- congenital muscular dystrophy with cerebellar involvement (Supportive), mode of inheritance: AR
- congenital muscular dystrophy with intellectual disability (Supportive), mode of inheritance: AR
- autosomal recessive limb-girdle muscular dystrophy type 2T (Strong), mode of inheritance: AR
- muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A14 (Strong), mode of inheritance: AR
- myopathy caused by variation in GMPPB (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14; Limb-girdle muscular dystrophy-dystroglycanopathy, type B, 14; Limb-girdle muscular dystrophy-dystroglycanopathy, type C, 14 | AR | Cardiovascular | Cardiovascular complications, including long QT syndrome and cardiomyopathy, have been described, and awareness may allow surveillance and prompt management | Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic | 23768512 |
ClinVar
This is a list of variants' phenotypes submitted to
- Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2T (303 variants)
- Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies),_type_A14 (300 variants)
- Muscular_dystrophy-dystroglycanopathy_(congenital_with_intellectual_disability),_type_B14 (294 variants)
- not_provided (120 variants)
- Inborn_genetic_diseases (39 variants)
- GMPPB-related_disorder (20 variants)
- not_specified (17 variants)
- Abnormality_of_the_musculature (6 variants)
- Elevated_circulating_creatine_kinase_concentration (2 variants)
- Muscular_dystrophy (2 variants)
- Muscular_dystrophy-dystroglycanopathy (2 variants)
- Myopathy_caused_by_variation_in_GMPPB (1 variants)
- Global_developmental_delay (1 variants)
- Limb-girdle_muscular_dystrophy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GMPPB gene is commonly pathogenic or not. These statistics are base on transcript: NM_000021971.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 75 | 79 | ||||
missense | 23 | 153 | 186 | |||
nonsense | 8 | |||||
start loss | 0 | |||||
frameshift | 13 | 20 | ||||
splice donor/acceptor (+/-2bp) | 12 | |||||
Total | 28 | 37 | 159 | 79 | 2 |
Highest pathogenic variant AF is 0.00095144
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GMPPB | protein_coding | protein_coding | ENST00000308375 | 8 | 7108 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
8.44e-7 | 0.759 | 125714 | 0 | 30 | 125744 | 0.000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.02 | 205 | 250 | 0.819 | 0.0000152 | 2498 |
Missense in Polyphen | 68 | 98.036 | 0.69362 | 1008 | ||
Synonymous | -0.454 | 108 | 102 | 1.06 | 0.00000605 | 800 |
Loss of Function | 1.28 | 12 | 17.8 | 0.674 | 8.10e-7 | 193 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000478 | 0.000478 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000793 | 0.0000703 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000294 | 0.000294 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the formation of GDP-mannose, an essential precursor of glycan moieties of glycoproteins and glycolipids. {ECO:0000250|UniProtKB:P0C5I2}.;
- Disease
- DISEASE: Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A14 (MDDGA14) [MIM:615350]: An autosomal recessive disorder characterized by congenital muscular dystrophy associated with brain anomalies, eye malformations, and profound mental retardation. The disorder includes a severe form designated as Walker-Warburg syndrome and a less severe phenotype known as muscle-eye-brain disease. MDDGA14 features include increased muscle tone, microcephaly, cleft palate, feeding difficulties, severe muscle weakness, sensorineural hearing loss, cerebellar hypoplasia, ataxia, and retinal dysfunction. {ECO:0000269|PubMed:23768512}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Muscular dystrophy-dystroglycanopathy congenital with mental retardation B14 (MDDGB14) [MIM:615351]: A congenital muscular dystrophy characterized by severe muscle weakness apparent in infancy and mental retardation. Some patients may have additional features, such as microcephaly, cardiac dysfunction, seizures, or cerebellar hypoplasia. {ECO:0000269|PubMed:23768512}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Muscular dystrophy-dystroglycanopathy limb-girdle C14 (MDDGC14) [MIM:615352]: An autosomal recessive form of muscular dystrophy characterized by mild proximal muscle weakness with onset in early childhood. Some patients may have additional features, such as mild intellectual disability or seizures. {ECO:0000269|PubMed:23768512, ECO:0000269|PubMed:26310427, ECO:0000269|PubMed:28433477, ECO:0000269|PubMed:28478914}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Fructose and mannose metabolism - Homo sapiens (human);Amino sugar and nucleotide sugar metabolism - Homo sapiens (human);Fructose intolerance, hereditary;Fructose and Mannose Degradation;Fructosuria;Fructose Mannose metabolism;Post-translational protein modification;Metabolism of proteins;Synthesis of GDP-mannose;Synthesis of substrates in N-glycan biosythesis;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;GDP-mannose biosynthesis
(Consensus)
Recessive Scores
- pRec
- 0.196
Intolerance Scores
- loftool
- rvis_EVS
- -0.34
- rvis_percentile_EVS
- 30.56
Haploinsufficiency Scores
- pHI
- 0.825
- hipred
- Y
- hipred_score
- 0.550
- ghis
- 0.423
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.976
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gmppb
- Phenotype
Zebrafish Information Network
- Gene name
- gmppb
- Affected structure
- skeletal muscle cell
- Phenotype tag
- abnormal
- Phenotype quality
- sparse
Gene ontology
- Biological process
- GDP-mannose biosynthetic process
- Cellular component
- cytoplasm
- Molecular function
- mannose-1-phosphate guanylyltransferase activity;protein binding;GTP binding